AAV gene therapy for Tay-Sachs disease. [PDF]
Nat Med, 2022 Flotte TR +29 more
europepmc +1 more source
Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum. [PDF]
Orphanet J Rare Dis, 2023 Ibrahim DMA +4 more
europepmc +1 more source
, 1974 One of the primary aims of the genetic counselor is the reduction in the number of children born with either lethal disorders or severe CNS dysfunction (eg. Mongolism and midline neural defects).
core +1 more source
Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease. [PDF]
Tremor Other Hyperkinet Mov (N Y), 2022 Riboldi GM, Lau H.
europepmc +1 more source
Late-Onset Tay-Sachs Disease in an Irish Family. [PDF]
Mov Disord Clin Pract, 2021 Lefter S +3 more
europepmc +1 more source
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. [PDF]
Cochrane Database Syst Rev, 2021 Hussein N, Henneman L, Kai J, Qureshi N.
europepmc +1 more source
Efficient and precise generation of Tay-Sachs disease model in rabbit by prime editing system. [PDF]
Cell Discov, 2021 Qian Y +9 more
europepmc +1 more source
Responsibility in financial innovation: retooling New Product Committees
, 2012 http://lse.ac.uk/riskAndRegulationMagazine http://www2.lse.ac.uk/researchAndExpertise/units/CARR/pdf/RR23_Summer-2012.pdfConsiders the potential contributions of New Product Committees to the development of responsible innovation in ...
Muniesa, Fabian
core +1 more source
Long-term follow-up of a Tay-Sachs disease patient with cherry-red spot. [PDF]
Am J Ophthalmol Case RepTsutsumi N +3 more
europepmc +1 more source
B4Galnt1 Deficiency Reverses Severe Neurological Symptoms in a Mouse Model of Tay-Sachs Disease. [PDF]
Neuromolecular MedYanbul S +3 more
europepmc +1 more source